Forty patients underwent intravesical chemotherapy with gemcitabine; of these patients, 18 had tumours that positively expressed RRM1, and 22 had tumours that negatively expressed RRM1 (Figure 1F, Table 2). The gene discussed is RRM1; the disease is neoplasm.